
Currently out of the existing stock ratings of Faisal Khurshid, 57 are a BUY (82.61%), 12 are a HOLD (17.39%).
Analyst Faisal Khurshid, currently employed at JEFFERIES, has had 54.33% of price targets met with an average potential upside of 29.22%, reached in 81 days on average.
Faisal Khurshid has documented 137 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VSTM, Verastem at 15-Oct-2026.
Analyst best performing recommendations are on RYTM (RHYTHM PHARMACEUTICALS).
The best stock recommendation documented was for RYTM (RHYTHM PHARMACEUTICALS) on 7/7/2025. The price target of $88 was fulfilled within 2 days with a profit of $21.61 (32.55%), with a performance score of 162.75.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Oct-2023
$20
$8.88 (79.86%)
$17
3 days ago
(15-Nov-2026)
Buy Since 10-Nov-2026
$15
$3.88 (34.89%)
$11
8 days ago
(10-Nov-2026)
2/5 (40%)
$3.03 (25.31%)
561
Buy Since 04-Jan-2021
$14
$2.88 (25.90%)
$9
9 days ago
(09-Nov-2026)
5/10 (50%)
$1.54 (12.36%)
312
Hold Since 23-Sep-2026
$13
$1.88 (16.91%)
$24
1 months 26 days ago
(23-Sep-2026)
1/3 (33.33%)
$0.35 (2.77%)
4
Buy Since 04-May-2026
$12
$0.88 (7.91%)
$11
3 months 13 days ago
(05-Aug-2026)
3/3 (100%)
$5.47 (83.77%)
53
Which stock is Faisal Khurshid most bullish on?
Which stock is Faisal Khurshid most reserved on?
What Year was the first public recommendation made by Faisal Khurshid?